Pediatric Gastroesophageal Reflux Clinical ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Auteur(s) :
Rosen, Rachel [Auteur]
Vandenplas, Yvan [Auteur]
Singendonk, Maartje [Auteur]
Cabana, Michael [Auteur]
Dilorenzo, Carlo [Auteur]
gottrand, Fréderic [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Gupta, Sandeep [Auteur]
Langendam, Miranda [Auteur]
Staiano, Annamaria [Auteur]
Thapar, Nikhil [Auteur]
Tipnis, Neelesh [Auteur]
Tabbers, Merit [Auteur]
Vandenplas, Yvan [Auteur]
Singendonk, Maartje [Auteur]
Cabana, Michael [Auteur]
Dilorenzo, Carlo [Auteur]
gottrand, Fréderic [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Gupta, Sandeep [Auteur]
Langendam, Miranda [Auteur]
Staiano, Annamaria [Auteur]
Thapar, Nikhil [Auteur]
Tipnis, Neelesh [Auteur]
Tabbers, Merit [Auteur]
Titre de la revue :
Journal of Pediatric Gastroenterology and Nutrition
Nom court de la revue :
J. Pediatr. Gastroenterol. Nutr.
Numéro :
66
Pagination :
516-554
Date de publication :
2018-03
ISSN :
1536-4801
Mot(s)-clé(s) :
gastroesophageal reflux disease
impedance
fundoplication
endoscopy
proton pump inhibitor
impedance
fundoplication
endoscopy
proton pump inhibitor
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
This document serves as an update of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) ...
Lire la suite >This document serves as an update of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) 2009 clinical guidelines for the diagnosis and management of gastroesophageal reflux disease (GERD) in infants and children and is intended to be applied in daily practice and as a basis for clinical trials. Eight clinical questions addressing diagnostic, therapeutic and prognostic topics were formulated. A systematic literature search was performed from October 1, 2008 (if the question was addressed by 2009 guidelines) or from inception to June 1, 2015 using Embase, MEDLINE, the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Clinical Trials. The approach of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) was applied to define and prioritize outcomes. For therapeutic questions, the quality of evidence was also assessed using GRADE. Grading the quality of evidence for other questions was performed according to the Quality Assessment of Studies of Diagnostic Accuracy (QUADAS) and Quality in Prognostic Studies (QUIPS) tools. During a 3-day consensus meeting, all recommendations were discussed and finalized. In cases where no randomized controlled trials (RCT; therapeutic questions) or diagnostic accuracy studies were available to support the recommendations, expert opinion was used. The group members voted on each recommendation, using the nominal voting technique. With this approach, recommendations regarding evaluation and management of infants and children with GERD to standardize and improve quality of care were formulated. Additionally, 2 algorithms were developed, 1 for infants <12 months of age and the other for older infants and children.Lire moins >
Lire la suite >This document serves as an update of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) 2009 clinical guidelines for the diagnosis and management of gastroesophageal reflux disease (GERD) in infants and children and is intended to be applied in daily practice and as a basis for clinical trials. Eight clinical questions addressing diagnostic, therapeutic and prognostic topics were formulated. A systematic literature search was performed from October 1, 2008 (if the question was addressed by 2009 guidelines) or from inception to June 1, 2015 using Embase, MEDLINE, the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Clinical Trials. The approach of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) was applied to define and prioritize outcomes. For therapeutic questions, the quality of evidence was also assessed using GRADE. Grading the quality of evidence for other questions was performed according to the Quality Assessment of Studies of Diagnostic Accuracy (QUADAS) and Quality in Prognostic Studies (QUIPS) tools. During a 3-day consensus meeting, all recommendations were discussed and finalized. In cases where no randomized controlled trials (RCT; therapeutic questions) or diagnostic accuracy studies were available to support the recommendations, expert opinion was used. The group members voted on each recommendation, using the nominal voting technique. With this approach, recommendations regarding evaluation and management of infants and children with GERD to standardize and improve quality of care were formulated. Additionally, 2 algorithms were developed, 1 for infants <12 months of age and the other for older infants and children.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Inserm
Université de Lille
CHU Lille
Université de Lille
CHU Lille
Équipe(s) de recherche :
Nutritional modulation of inflammation and infection
Date de dépôt :
2019-03-01T14:46:27Z
2019-09-24T07:50:21Z
2024-01-24T18:04:26Z
2019-09-24T07:50:21Z
2024-01-24T18:04:26Z